In-Silico Characterization of von Willebrand Factor Bound to FVIII
Factor VIII belongs to the coagulation cascade and is expressed as a long pre-protein (mature form, 2351 amino acids long). FVIII is deficient or defective in hemophilic A patients, who need to be treated with hemoderivatives or recombinant FVIII substitutes, i.e., biologic drugs. The interaction be...
Main Authors: | Valentina Drago, Luisa Di Paola, Claire Lesieur, Renato Bernardini, Claudio Bucolo, Chiara Bianca Maria Platania |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/12/15/7855 |
Similar Items
-
Immune Tolerance Induction (ITI) with a pdFVIII/VWF Concentrate (octanate) in 100 Patients in the Observational ITI (ObsITI) Study
by: Carmen Escuriola Ettingshausen, et al.
Published: (2022-04-01) -
Platelets compensate for poor thrombin generation in type 3 von Willebrand disease
by: Timea Szanto, et al.
Published: (2020-01-01) -
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
by: Castaman G, et al.
Published: (2016-06-01) -
Splenic vascular malformation in a patient with von Willebrand disease and hemophilia
by: Ying-Chia Wu, et al.
Published: (2023-04-01) -
The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)